Tactile Systems Technology, Inc. TCMD
NASDAQ · United States · Health Technology
$22.10+0.39 (+1.80%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Moby summary of Tactile Systems Technology, Inc.'s Q2 2026 earnings call
MINNEAPOLIS, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the second quarter ended June 30, 2026. Second Quarter 2026 Summary and Recent Business Highlights: Total revenue increased 9% year-over-year to $85.7 millionGross margin expanded to 76% from 75% in Q2 2025Net income increased to $7.8 million from
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.